Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to examine the safety profile of Eliquis in Korean nonvalvular atrial fibrillation patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01885598
Study type Observational
Source Bristol-Myers Squibb
Contact
Status Completed
Phase N/A
Start date July 10, 2013
Completion date September 29, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT04586972 - Safety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Prospective reAl World Study;
Completed NCT02007655 - Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation
Completed NCT02674594 - Evaluation of Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation (NVAF) Patients in the US N/A
Recruiting NCT04494347 - Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR) N/A
Not yet recruiting NCT04942873 - The Adherence to Oral Anticoagulant in Chinese Patients With NVAF
Recruiting NCT05731882 - First in Man Study of Left Atrial Appendage Pulsed Field Ablation Occluder N/A
Completed NCT02919982 - Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation
Completed NCT00684307 - Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation Phase 2
Recruiting NCT04073316 - AntiCoagulants and COGnition Phase 4
Completed NCT03374540 - Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients
Recruiting NCT05715658 - Pharmacokinetic Study to Evaluate Dabigatran Etexilate in Elderly Subjects N/A